Balyasny Asset Management LLC Enanta Pharmaceuticals Inc Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$11.09 - $22.13 $466,489 - $930,876
42,064 New
42,064 $469,000
Q3 2019

Nov 14, 2019
SELL
$60.08 - $88.17 $661,661 - $971,016
-11,013 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$81.3 - $97.35 $98,373 - $117,793
1,210 Added 12.34%
11,013 $929,000
Q1 2019

May 15, 2019
BUY
$69.08 - $105.66 $677,191 - $1.04 Million
9,803 New
9,803 $936,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email